nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.0488	0.0666	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.0451	0.0616	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Interferon gamma signaling—PML—Paget's disease of bone	0.0401	0.0547	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelin Pathways—CALCA—Paget's disease of bone	0.0349	0.0476	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Nuclear Envelope Breakdown—NUP205—Paget's disease of bone	0.0337	0.046	CbGpPWpGaD
Ingenol Mebutate—PRKCD—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.0294	0.0402	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.0259	0.0354	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.0252	0.0344	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—ALPL—Paget's disease of bone	0.0242	0.033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—mTOR signaling pathway—PML—Paget's disease of bone	0.0239	0.0326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.023	0.0314	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Interferon Signaling—NUP205—Paget's disease of bone	0.0221	0.0302	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Interferon Signaling—PML—Paget's disease of bone	0.0196	0.0267	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.0195	0.0267	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.0192	0.0263	CbGpPWpGaD
Ingenol Mebutate—Ulcer—Alendronate—Paget's disease of bone	0.0183	0.0684	CcSEcCtD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.0176	0.0241	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—NUP205—Paget's disease of bone	0.0154	0.021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic Prophase—NUP205—Paget's disease of bone	0.0151	0.0207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.0148	0.0202	CbGpPWpGaD
Ingenol Mebutate—Ulcer—Risedronate—Paget's disease of bone	0.0147	0.0549	CcSEcCtD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.0131	0.0178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.0126	0.0172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.0113	0.0154	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.0112	0.0153	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—SQSTM1—Paget's disease of bone	0.0111	0.0152	CbGpPWpGaD
Ingenol Mebutate—Swelling—Pamidronate—Paget's disease of bone	0.0109	0.0406	CcSEcCtD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.0102	0.0139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.0101	0.0138	CbGpPWpGaD
Ingenol Mebutate—Swelling—Zoledronate—Paget's disease of bone	0.00993	0.0371	CcSEcCtD
Ingenol Mebutate—Eye pain—Zoledronate—Paget's disease of bone	0.00971	0.0363	CcSEcCtD
Ingenol Mebutate—Headache—Tiludronate—Paget's disease of bone	0.00949	0.0355	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00902	0.0337	CcSEcCtD
Ingenol Mebutate—Erythema—Etidronic acid—Paget's disease of bone	0.00889	0.0332	CcSEcCtD
Ingenol Mebutate—PRKCA—Metabolism of RNA—NUP205—Paget's disease of bone	0.00885	0.0121	CbGpPWpGaD
Ingenol Mebutate—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.00858	0.0321	CcSEcCtD
Ingenol Mebutate—PRKCA—M Phase—NUP205—Paget's disease of bone	0.00815	0.0111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00786	0.0107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—INPP5D—Paget's disease of bone	0.00785	0.0107	CbGpPWpGaD
Ingenol Mebutate—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.00784	0.0293	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Risedronate—Paget's disease of bone	0.00778	0.0291	CcSEcCtD
Ingenol Mebutate—Infestation—Risedronate—Paget's disease of bone	0.00778	0.0291	CcSEcCtD
Ingenol Mebutate—Erythema—Alendronate—Paget's disease of bone	0.00757	0.0283	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Risedronate—Paget's disease of bone	0.00756	0.0282	CcSEcCtD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—NUP205—Paget's disease of bone	0.00747	0.0102	CbGpPWpGaD
Ingenol Mebutate—Infestation NOS—Pamidronate—Paget's disease of bone	0.00739	0.0276	CcSEcCtD
Ingenol Mebutate—Infestation—Pamidronate—Paget's disease of bone	0.00739	0.0276	CcSEcCtD
Ingenol Mebutate—Infection—Etidronic acid—Paget's disease of bone	0.00721	0.0269	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00719	0.0268	CcSEcCtD
Ingenol Mebutate—PRKCA—Cell Cycle—OPTN—Paget's disease of bone	0.00703	0.00959	CbGpPWpGaD
Ingenol Mebutate—Infestation NOS—Zoledronate—Paget's disease of bone	0.00675	0.0252	CcSEcCtD
Ingenol Mebutate—Infestation—Zoledronate—Paget's disease of bone	0.00675	0.0252	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00656	0.0245	CcSEcCtD
Ingenol Mebutate—Eye disorder—Risedronate—Paget's disease of bone	0.00652	0.0244	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00638	0.00872	CbGpPWpGaD
Ingenol Mebutate—Eye disorder—Pamidronate—Paget's disease of bone	0.0062	0.0232	CcSEcCtD
Ingenol Mebutate—Infection—Alendronate—Paget's disease of bone	0.00614	0.0229	CcSEcCtD
Ingenol Mebutate—PRKCD—Disease—VCP—Paget's disease of bone	0.00584	0.00797	CbGpPWpGaD
Ingenol Mebutate—Erythema—Pamidronate—Paget's disease of bone	0.00578	0.0216	CcSEcCtD
Ingenol Mebutate—Eye disorder—Zoledronate—Paget's disease of bone	0.00566	0.0212	CcSEcCtD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.00558	0.00762	CbGpPWpGaD
Ingenol Mebutate—Erythema—Zoledronate—Paget's disease of bone	0.00528	0.0197	CcSEcCtD
Ingenol Mebutate—PRKCA—Cell Cycle—NUP205—Paget's disease of bone	0.00499	0.00682	CbGpPWpGaD
Ingenol Mebutate—Infection—Risedronate—Paget's disease of bone	0.00493	0.0184	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Risedronate—Paget's disease of bone	0.00486	0.0182	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—NUP205—Paget's disease of bone	0.00483	0.0066	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NUP205—Paget's disease of bone	0.0048	0.00656	CbGpPWpGaD
Ingenol Mebutate—Infection—Pamidronate—Paget's disease of bone	0.00468	0.0175	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00462	0.0173	CcSEcCtD
Ingenol Mebutate—Headache—Etidronic acid—Paget's disease of bone	0.00454	0.017	CcSEcCtD
Ingenol Mebutate—PRKCA—Hemostasis—INPP5D—Paget's disease of bone	0.00451	0.00616	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NUP205—Paget's disease of bone	0.00446	0.00609	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00432	0.0059	CbGpPWpGaD
Ingenol Mebutate—Infection—Zoledronate—Paget's disease of bone	0.00428	0.016	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—PML—Paget's disease of bone	0.00427	0.00583	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00422	0.0158	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—INPP5D—Paget's disease of bone	0.00412	0.00562	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VCP—Paget's disease of bone	0.00409	0.00558	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CALCA—Paget's disease of bone	0.00392	0.00536	CbGpPWpGaD
Ingenol Mebutate—Headache—Alendronate—Paget's disease of bone	0.00387	0.0145	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—SQSTM1—Paget's disease of bone	0.00369	0.00504	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—VCP—Paget's disease of bone	0.00335	0.00458	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CALCA—Paget's disease of bone	0.00331	0.00452	CbGpPWpGaD
Ingenol Mebutate—Headache—Risedronate—Paget's disease of bone	0.00311	0.0116	CcSEcCtD
Ingenol Mebutate—Headache—Pamidronate—Paget's disease of bone	0.00295	0.011	CcSEcCtD
Ingenol Mebutate—PRKCA—Immune System—NUP205—Paget's disease of bone	0.00277	0.00379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NUP205—Paget's disease of bone	0.00276	0.00377	CbGpPWpGaD
Ingenol Mebutate—Headache—Zoledronate—Paget's disease of bone	0.0027	0.0101	CcSEcCtD
Ingenol Mebutate—PRKCA—Disease—NUP205—Paget's disease of bone	0.00256	0.0035	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CALCA—Paget's disease of bone	0.00248	0.00339	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PML—Paget's disease of bone	0.00245	0.00335	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00239	0.00326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—INPP5D—Paget's disease of bone	0.00237	0.00323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VCP—Paget's disease of bone	0.00235	0.0032	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CALCA—Paget's disease of bone	0.00232	0.00317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CALCA—Paget's disease of bone	0.00225	0.00308	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NUP205—Paget's disease of bone	0.00215	0.00293	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SQSTM1—Paget's disease of bone	0.00212	0.0029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CALCA—Paget's disease of bone	0.0019	0.0026	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—INPP5D—Paget's disease of bone	0.00183	0.0025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00137	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CALCA—Paget's disease of bone	0.00133	0.00182	CbGpPWpGaD
